K2 Principal Fund’s Pasithea Therapeutics KTTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-14,122
Closed -$181K 231
2022
Q4
$181K Sell
14,122
-10,468
-43% -$134K 0.03% 88
2022
Q3
$620K Hold
24,590
0.07% 76
2022
Q2
$497K Sell
24,590
-2,910
-11% -$58.8K 0.05% 122
2022
Q1
$715K Hold
27,500
0.06% 89
2021
Q4
$973K Buy
+27,500
New +$973K 0.06% 127